Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.
about
metabolic profiling of Parkinson's disease and mild cognitive impairment.Association between Oxidative DNA Damage and Risk of Colorectal Cancer: Sensitive Determination of Urinary 8-Hydroxy-2'-deoxyguanosine by UPLC-MS/MS AnalysisGlobal metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and stagingIntegration of Traditional and Metabolomics Biomarkers Identifies Prognostic Metabolites for Predicting Responsiveness to Nutritional Intervention against Oxidative Stress and Inflammation.Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.Proteomics and metabolomics in ageing research: from biomarkers to systems biology.Discriminating patients with early-stage breast cancer from benign lesions by detection of oxidative DNA damage biomarker in urine.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.Amyloid β42 peptide is toxic to non-neural cells in Drosophila yielding a characteristic metabolite profile and the effect can be suppressed by PI3K.Feline urine metabolomic signature: characterization of low-molecular-weight substances in urine from domestic cats.Using an NMR metabolomics approach to investigate the pathogenicity of amyloid-beta and alpha-synuclein.How important is tryptophan in human health?Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.A glimmer of light at the end of the tunnel?Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.
P2860
Q33835701-CCA17500-218D-4925-B68C-7E75167126D8Q37227694-BE9F2EC6-474D-41A7-9ED1-238FAD612632Q37325367-9A0C3BF5-10E0-4FF0-9E7D-869506D5311AQ37729705-09AFC476-86D1-41A3-8AAC-DB756D3F3279Q38639708-16DB3F70-B56E-41B6-8DBB-2221A596E53AQ38690133-BBBA20F1-3C0E-47D2-8B47-9A8FF985F599Q38719357-1A92CE87-BEB9-4106-B83C-181F17DB4CD9Q39429374-832BA75C-96A5-4075-8F0E-62A10A79D0FAQ41593052-350A4A57-72CB-48BE-95DA-FDA5D0B99EF0Q41666702-6128AD6E-771F-42F4-8DF6-A7907C7BD23AQ47151964-7132BD78-164D-4B44-8596-9C13D001995DQ47224149-3CEDF6C7-A707-4C1C-A9CC-E179EFE1FEDDQ47397920-8DE5CD23-75CC-4CCD-BF14-E1501E78AEB1Q47698588-A925ACBE-720B-45D3-89D1-E03B526A2A06Q47972723-23E9938C-96EF-4070-8835-3BC4C7759804Q50045364-075396B9-6572-41BF-8ACA-1DD73B28908BQ51761574-27793AD2-AC07-4F3A-8580-1B1AF706B687
P2860
Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comprehensive urinary metabolo ...... diopathic Parkinson's disease.
@ast
Comprehensive urinary metabolo ...... diopathic Parkinson's disease.
@en
type
label
Comprehensive urinary metabolo ...... diopathic Parkinson's disease.
@ast
Comprehensive urinary metabolo ...... diopathic Parkinson's disease.
@en
prefLabel
Comprehensive urinary metabolo ...... diopathic Parkinson's disease.
@ast
Comprehensive urinary metabolo ...... diopathic Parkinson's disease.
@en
P2093
P2860
P50
P356
P1433
P1476
Comprehensive urinary metabolo ...... diopathic Parkinson's disease.
@en
P2093
Ka-Kit Chua
Liang-Feng Liu
Manwen Zhang
P2860
P2888
P356
10.1038/SREP13888
P407
P577
2015-09-14T00:00:00Z